IBD 50's Top Stock, ADMA Biologics, Crashes After Auditor Unexpectedly Resigns
In this article:
ADMA stock plummeted Thursday after the company's auditor unexpectedly resigned. But ADMA Biologics kept its guidance for this year and next.
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
ADMA stock plummeted Thursday after the company's auditor unexpectedly resigned. But ADMA Biologics kept its guidance for this year and next.